News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Exploiting the cell cycle to improve radiotherapy outcomes
One of the crucial signalling networks that often go awry in cancer are those that respond to DNA damage and regulate the cell cycle progression. But now researchers are turning this to their advantage, and are attacking cancer by targeting one of the very processes that drives it – a faulty DNA repair response.
Statement in response to rejection of abiraterone before chemotherapy in final draft guidance from NICE
Our Interim Chief Executive, Professor Paul Workman, comments on today’s rejection of abiraterone before chemotherapy in final draft guidance from NICE.
Mutations in a gene essential for cell regulation cause kidney cancer in children
Mutations in a gene that helps regulate when genes are switched on and off in cells have been found to cause rare cases of Wilms tumour, the most common kidney cancer occurring in children.
Cancer drug improves quality of life in men with incurable prostate cancer
New study shows enzalutamide improves the quality of life of patients with advanced, incurable prostate cancer.
Childhood brain tumours: breakthrough could speed new treatments
Imaging study raises hope for young patients
Cause of rare childhood cancer discovered
Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS).
Viral therapy could boost limb-saving cancer treatment
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
Scientists map one of most important proteins in life – and cancer
Research carried out at the ICR has revealed the structure of one of the most important and complicated proteins in cell division – a fundamental process the development of cancer.
ICR launches new website to showcase its world-class research
The Institute of Cancer Research, London, today launches a sophisticated new website designed to use news and multimedia to provide the public with a window onto its world-leading cancer research.
-vasculature-of-the-mouse-retina-matthew-ashenden-the-icr-2011-1.jpg?sfvrsn=bc35b7e5_2 "(4:3) Vasculature of the mouse retina. Matthew Ashenden / the ICR, 2011-1")
Darwinian evolution: from dinosaurs to cancer drug resistance
Birds evolving from dinosaurs, fish emerging from the sea, and hominids adopting an upright posture – all are iconic examples of evolution. On the surface they don’t have a great deal to do with cancer, but the process underlying them both — natural selection — is identical.
.jpg?sfvrsn=5ee5f73f_2 "Breast epithelial cells under ER stress (Chris Bakal, 2014)")
Signal may send cancer’s cellular factories into overdrive
A network of signals active in almost all types of cancer sends the protein factories in our cells into overdrive, and may help fuel a tumour’s uncontrolled growth, Chelsea scientists have found.
ICR awards ceremony celebrates achievements of new cancer research graduates
Students, public figures and academics were honoured during the annual awards ceremony for graduates of The Institute of Cancer Research, London.
